An Algorithm for Classifying Patients Most Likely to Develop Severe Coronavirus Disease 2019 Illness.
coronavirus disease 2019
hospitalization
intensive care
outcome prediction
pandemic
severe acute respiratory syndrome coronavirus 2
Journal
Critical care explorations
ISSN: 2639-8028
Titre abrégé: Crit Care Explor
Pays: United States
ID NLM: 101746347
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
entrez:
23
12
2020
pubmed:
24
12
2020
medline:
24
12
2020
Statut:
epublish
Résumé
To develop an algorithm that predicts an individualized risk of severe coronavirus disease 2019 illness (i.e., ICU admission or death) upon testing positive for coronavirus disease 2019. A retrospective cohort study. Cleveland Clinic Health System. Those hospitalized with coronavirus disease 2019 between March 8, 2020, and July 13, 2020. A temporal coronavirus disease 2019 test positive cut point of June 1 was used to separate the development from validation cohorts. Fine and Gray competing risk regression modeling was performed. The development set contained 4,520 patients who tested positive for coronavirus disease 2019 between March 8, 2020, and May 31, 2020. The validation set contained 3,150 patients who tested positive between June 1 and July 13. Approximately 9% of patients were admitted to the ICU or died of coronavirus disease 2019 within 2 weeks of testing positive. A prediction cut point of 15% was proposed. Those who exceed the cutoff have a 21% chance of future severe coronavirus disease 2019, whereas those who do not have a 96% chance of avoiding the severe coronavirus disease 2019. In addition, application of this decision rule identifies 89% of the population at the very low risk of severe coronavirus disease 2019 (< 4%). We have developed and internally validated an algorithm to assess whether someone is at high risk of admission to the ICU or dying from coronavirus disease 2019, should he or she test positive for coronavirus disease 2019. This risk should be a factor in determining resource allocation, protection from less safe working conditions, and prioritization for vaccination.
Identifiants
pubmed: 33354674
doi: 10.1097/CCE.0000000000000300
pmc: PMC7746202
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e0300Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR002548
Pays : United States
Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.
Déclaration de conflit d'intérêts
The authors have disclosed that they do not have any potential conflicts of interest.
Références
Semin Urol Oncol. 2002 May;20(2):79-81
pubmed: 12030248
Stat Med. 1996 Feb 28;15(4):361-87
pubmed: 8668867
Cell Discov. 2020 Mar 16;6:14
pubmed: 32194980
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Circulation. 2015 Jan 13;131(2):211-9
pubmed: 25561516
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Kidney Int. 2020 Jun;97(6):1076-1082
pubmed: 32354637
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Am J Transplant. 2020 Jul;20(7):1859-1863
pubmed: 32181990
J Heart Lung Transplant. 2020 May;39(5):496-497
pubmed: 32362394
Chest. 2020 Oct;158(4):1364-1375
pubmed: 32533957
J Infect. 2020 May;80(5):e1-e6
pubmed: 32171869
Chin Med J (Engl). 2020 May 5;133(9):1032-1038
pubmed: 32118640
Am J Transplant. 2020 Jul;20(7):1879-1881
pubmed: 32243697
Ann Transl Med. 2018 Feb;6(3):42
pubmed: 29610734
Clin Pharmacol Ther. 2020 Aug;108(2):236-241
pubmed: 32320478
JAMA Cardiol. 2020 Sep 1;5(9):1020-1026
pubmed: 32936273
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Lancet Gastroenterol Hepatol. 2020 Jun;5(6):532-533
pubmed: 32278366